CS231964B2 - Manufacturing process of flavanoe derivatives - Google Patents

Manufacturing process of flavanoe derivatives Download PDF

Info

Publication number
CS231964B2
CS231964B2 CS791690A CS169079A CS231964B2 CS 231964 B2 CS231964 B2 CS 231964B2 CS 791690 A CS791690 A CS 791690A CS 169079 A CS169079 A CS 169079A CS 231964 B2 CS231964 B2 CS 231964B2
Authority
CS
Czechoslovakia
Prior art keywords
substituents
groups
substituent
derivatives
formula
Prior art date
Application number
CS791690A
Other languages
Czech (cs)
English (en)
Inventor
John F Batchelor
Denis J Bauer
Harold F Hodson
John W T Selway
David A B Young
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to CS80430A priority Critical patent/CS231968B2/cs
Priority to CS80431A priority patent/CS231969B2/cs
Publication of CS231964B2 publication Critical patent/CS231964B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
CS791690A 1978-03-15 1979-03-14 Manufacturing process of flavanoe derivatives CS231964B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CS80430A CS231968B2 (cs) 1978-03-15 1980-01-22 Způsob výroby flavanových derivátů
CS80431A CS231969B2 (en) 1978-03-15 1980-01-22 Manufacturing process of flavanoe derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1025178 1978-03-15

Publications (1)

Publication Number Publication Date
CS231964B2 true CS231964B2 (en) 1985-01-16

Family

ID=9964425

Family Applications (1)

Application Number Title Priority Date Filing Date
CS791690A CS231964B2 (en) 1978-03-15 1979-03-14 Manufacturing process of flavanoe derivatives

Country Status (32)

Country Link
US (1) US4461907A (ru)
EP (2) EP0051061A3 (ru)
JP (1) JPS54130575A (ru)
AR (2) AR223478A1 (ru)
AT (1) AT366681B (ru)
AU (1) AU529313B2 (ru)
CA (1) CA1193273A (ru)
CS (1) CS231964B2 (ru)
DD (1) DD142340A5 (ru)
DK (1) DK105379A (ru)
EG (1) EG14189A (ru)
ES (3) ES478605A1 (ru)
FI (1) FI790863A (ru)
GR (1) GR67250B (ru)
HU (2) HU187755B (ru)
IL (1) IL56871A (ru)
IN (2) IN150229B (ru)
IT (1) IT1116848B (ru)
MC (1) MC1254A1 (ru)
MY (1) MY8500223A (ru)
NO (3) NO154167C (ru)
NZ (1) NZ189906A (ru)
OA (1) OA06289A (ru)
PH (1) PH18415A (ru)
PL (3) PL214115A1 (ru)
PT (1) PT69349A (ru)
RO (4) RO82173B (ru)
SU (3) SU1072805A3 (ru)
YU (3) YU61679A (ru)
ZA (1) ZA791198B (ru)
ZM (1) ZM2479A1 (ru)
ZW (1) ZW5979A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193316A (en) * 1979-04-10 1984-07-31 Hoffmann La Roche 3-alkoxyflavone derivatives and pharmaceutical compositions
US4588733A (en) * 1984-10-19 1986-05-13 Merrell Dow Pharmaceuticals Inc. 2-phenylpyrano[2,3-b]pyridines and their use in inhibiting viruses
US4758679A (en) * 1986-07-18 1988-07-19 Pennwalt Corporation Preparation of 7-(3-(propylamino)-2-hydroxypropoxy)flavone
LU86715A1 (fr) * 1986-12-16 1988-07-14 Oreal Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation
KR0139296B1 (ko) * 1988-11-21 1998-05-15 가와무라 시게꾸니 칼콘 유도체 및 그 제조 방법
US5063244A (en) * 1990-07-30 1991-11-05 Development Center For Biotechnology Process for the isolation of antifungal agents (5-methoxy-7-hydroxyflavan) from dragon's blood resin and its use in agriculture
US5276058A (en) * 1993-06-09 1994-01-04 Nippon Hypox Laboratories Incorporated 3,4-dihydroxychalcone derivatives
IL118657A0 (en) 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
AU6174900A (en) 1999-07-08 2001-01-30 Patrick T. Prendergast Use of flavones, coumarins and related compounds to treat infections
US6677350B1 (en) 1999-09-22 2004-01-13 Advanced Life Sciences, Inc. Beta-fluoroethyl thiourea compounds and use
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Ｊｎｃ株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
EP1491612B1 (en) * 2003-06-23 2006-10-18 Chisso Petrochemical Corporation Chroman compound, liquid crystal composition including the compound and liquid crystal display element including the liquid crystal composition
CN102210663B (zh) 2004-05-28 2013-07-31 尤尼根公司 作为双核酶强效抑制剂的二芳基烷烃
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
JP5126942B2 (ja) * 2006-12-26 2013-01-23 静岡県公立大学法人 ５，７−ジデオキシエピガロカテキンガレート、その製法及び抗インフルエンザウイルス剤
JP6621400B2 (ja) * 2013-04-04 2019-12-18 スファエラ ファーマ プライベート リミテッド エピカテキン及び関連したポリフェノールの新規な類縁体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518006A1 (de) * 1951-01-28 1969-01-16 Merck Ag E Verfahren zur Herstellung von wasserloeslichen Flavanoidderivaten
FR1221869A (fr) * 1959-01-15 1960-06-07 Coupin Lab Procédé de préparation de dérivés solubles dans l'eau à partir des glucosides flavanoniques
ES265050A1 (es) * 1960-02-23 1961-06-16 Orsymonde Ltd Procedimiento de preparación de derivados insaturados de la trihidroxiacetofenona
CH473114A (de) * 1963-08-28 1969-05-31 Merck Ag E Verfahren zur Herstellung von substituierten Flavanoiden
DE1493976C3 (de) * 1964-01-18 1973-09-13 Merck Patent Gmbh, 6100 Darmstadt Substituierte Flavandenvate sowie Verfahren zu ihrer Herstellung
US3499763A (en) * 1967-05-01 1970-03-10 Ibm Bis phenols as high opacity diazotype couplers
FR1583930A (ru) * 1968-06-27 1969-12-05
GB1283981A (en) * 1969-03-05 1972-08-02 Orsymonde 2,4,6-trihydroxy chalcone derivatives
US3678044A (en) * 1970-10-22 1972-07-18 Chevron Res Substituted flavanones
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0051061A2 (en) 1982-05-05
ES478605A1 (es) 1980-01-16
IN150229B (ru) 1982-08-21
FI790863A (fi) 1979-09-16
YU271582A (en) 1983-02-28
IT1116848B (it) 1986-02-10
MC1254A1 (fr) 1980-01-14
ATA191879A (de) 1981-09-15
PL214115A1 (ru) 1980-06-16
DD142340A5 (de) 1980-06-18
EG14189A (en) 1984-09-30
JPS54130575A (en) 1979-10-09
RO86258A (fr) 1985-03-15
DK105379A (da) 1979-09-16
EP0004579A1 (en) 1979-10-17
NO840627L (no) 1979-09-18
ZA791198B (en) 1980-11-26
AR223478A1 (es) 1981-08-31
HUT35173A (en) 1985-06-28
SU986296A3 (ru) 1982-12-30
MY8500223A (en) 1985-12-31
NO154167B (no) 1986-04-21
RO86258B (ro) 1985-03-31
RO78419A (ro) 1982-03-24
PL122049B1 (en) 1982-06-30
PT69349A (en) 1979-04-01
US4461907A (en) 1984-07-24
HU187755B (en) 1986-02-28
RO82526A (ro) 1984-10-31
NO790871L (no) 1979-09-18
YU271482A (en) 1983-02-28
AT366681B (de) 1982-04-26
NO840626L (no) 1979-09-18
AU529313B2 (en) 1983-06-02
ES482787A1 (es) 1980-08-01
ZM2479A1 (en) 1981-01-21
AU4510879A (en) 1979-09-20
RO82173A (ro) 1984-04-02
NZ189906A (en) 1985-07-31
IN151598B (ru) 1983-06-04
GR67250B (ru) 1981-06-25
RO82173B (ro) 1984-04-30
EP0004579B1 (en) 1982-08-18
SU991948A3 (ru) 1983-01-23
ES482788A1 (es) 1980-09-01
IL56871A0 (en) 1979-05-31
IT7948347A0 (it) 1979-03-14
NO154167C (no) 1986-07-30
CA1193273A (en) 1985-09-10
AR225175A1 (es) 1982-02-26
RO82526B (ro) 1984-11-30
SU1072805A3 (ru) 1984-02-07
OA06289A (fr) 1981-06-30
PL121969B1 (en) 1982-06-30
EP0051061A3 (en) 1982-06-09
YU61679A (en) 1983-02-28
IL56871A (en) 1986-02-28
PH18415A (en) 1985-06-24
ZW5979A1 (en) 1980-10-15

Similar Documents

Publication Publication Date Title
CS231964B2 (en) Manufacturing process of flavanoe derivatives
US4767788A (en) Glutaric acid virucidal processes and compositions
CZ132794A3 (en) Immunopotentiating preparation
CZ288382B6 (en) Pharmaceutical preparation for treating viral infections
KR20220146496A (ko) 뉴클레오티드계 화합물의 코로나 바이러스 감염증의 치료에의 사용
CN105748476A (zh) 亚氨基糖以及治疗丝状病毒性疾病的方法
EP4161524A1 (en) Methods of treating a coronavirus infection
US6362207B1 (en) Methods of treating viral infections with benzimidazoles
US6686393B1 (en) Pharmaceutical compositions having antiviral activity against human cytomegalovirus
EP0610444B1 (en) Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases
McKinlay et al. Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice
Sidwell et al. In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin
WO2021221537A1 (ru) Противо-sars-cov-2 вирусное средство антипровир
Peters et al. The experimental chemotherapy of leishmaniasis, V: The activity of potential leishmanicides against ‘L. infantum LV9’in NMRI mice
Eaton et al. Further observations of the effect of acridines on the growth of viruses
WO2022143710A1 (zh) 吡咯喹啉醌、其衍生物和/或盐作为抗病毒新药的用途及其药物组合物
RU2738885C1 (ru) Противо-SARS-CoV-2 вирусное средство Антипровир
US6140371A (en) Therapeutic uses of known ester and amide compounds
US4617311A (en) Antiasthmatic method
WO2021207271A1 (en) Organoselenide glutathione peroxidase mimetics for the treatment of inflammatory pulmonary disorders
WO2005013980A1 (en) Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions.
Diana et al. Chemotherapy of virus diseases
KR101045985B1 (ko) 아릴 디케토산（ａｄｋ） 유도체를 유효성분으로 포함하는 사스 코로나 바이러스 저해용 조성물
SE451070B (sv) Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom
CN101084892A (zh) 一种抗呼吸道病毒的药物及用途